Bank of Montreal’s Roivant Sciences ROIV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.49M Sell
42,223
-1,562
-4% -$46.2K ﹤0.01% 1886
2026
Q1
$1.21M Buy
43,785
+3,773
+9% +$96.9K ﹤0.01% 1932
2025
Q4
$868K Buy
40,012
+516
+1% +$10.2K ﹤0.01% 2053
2025
Q3
$598K Sell
39,496
-1,857
-4% -$23K ﹤0.01% 2190
2025
Q2
$466K Sell
41,353
-4,627
-10% -$50.2K ﹤0.01% 2325
2025
Q1
$464K Sell
45,980
-2,046
-4% -$22.1K ﹤0.01% 2248
2024
Q4
$568K Buy
48,026
+8,084
+20% +$95.6K ﹤0.01% 2164
2024
Q3
$459K Buy
39,942
+9,410
+31% +$107K ﹤0.01% 2483
2024
Q2
$338K Buy
30,532
+2,104
+7% +$23.1K ﹤0.01% 2660
2024
Q1
$318K Buy
+28,428
New +$307K ﹤0.01% 2744

Other funds holding ROIV

Bank of Montreal's ROIV Position: Q2 2026 in Review

Bank of Montreal reduced its Roivant Sciences (ROIV) stake by 3.6% in Q2 2026, selling an estimated $46.2K and leaving 42,223 shares worth $1.49M. The position accounts for ﹤0.01% of the portfolio, ranked #1886.

Bank of Montreal first reported a position in ROIV in Q1 2024 and has held it in 10 quarters since. 464 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • Bank of Montreal held 42,223 shares of Roivant Sciences worth $1.49M as of Q2 2026.
  • Bank of Montreal sold 1,562 Roivant Sciences shares in Q2 2026, an estimated $46.2K.
  • Roivant Sciences made up ﹤0.01% of Bank of Montreal's portfolio in Q2 2026, its #1886 holding.
  • Bank of Montreal first reported a position in Roivant Sciences in Q1 2024 and has held it in 10 quarters since.
  • 464 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Bank of Montreal's 13F filing for Q2 2026, filed 12 Aug 2026.